神经分泌生物科学(NBIX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NBIX 神经分泌生物科学

盘后交易 04-16 19:02:52 EDT

132.99

+1.25

+0.95%

盘后133.00

+0.01+0.01%

18:16 EDT

最高135.18	最低131.49	成交量103.32万
今开131.78	昨收131.74	日振幅2.80%
总市值133.76亿	流通市值132.03亿	总股本1.01亿
成交额1.38亿	换手率1.04%	流通股本9,928万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"NBIX","market":"US","secType":"STK","nameCN":"神经分泌生物科学","latestPrice":132.99,"timestamp":1713297600000,"preClose":131.74,"halted":0,"volume":1033219,"hourTrading":{"tag":"盘后","latestPrice":133,"preClose":132.99,"latestTime":"18:16 EDT","volume":75663,"amount":10062423.883259999,"timestamp":1713305765955},"delay":0,"floatShares":99277687,"shares":100580497,"eps":2.47,"marketStatus":"盘后交易","marketStatusCode":4,"change":1.25,"latestTime":"04-16 19:02:52 EDT","open":131.78,"high":135.18,"low":131.49,"amount":138222653.30654,"amplitude":0.02801,"askPrice":135.5,"askSize":5,"bidPrice":131,"bidSize":1,"shortable":3,"etf":0,"ttmEps":2.47,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1713312000000},"adr":0,"listingDate":832824000000,"adjPreClose":131.74,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":131.78,"preClose":131.74,"latestTime":"09:29 EDT","volume":719,"amount":94804.90259,"timestamp":1713274199998},"postHourTrading":{"tag":"盘后","latestPrice":133,"preClose":132.99,"latestTime":"18:16 EDT","volume":75663,"amount":10062423.883259999,"timestamp":1713305765955},"volumeRatio":1.523087},"requestUrl":"/m/hq/s/NBIX","defaultTab":"news","newsList":[{"id":"2422915817","title":"神经分泌生物科学盘中异动 股价大跌5.37%报133.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422915817","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422915817?lang=zh_cn&edition=full","pubTime":"2024-03-27 22:11","pubTimestamp":1711548673,"startTime":"0","endTime":"0","summary":"北京时间2024年03月27日22时11分，神经分泌生物科学股票出现异动，股价大幅跳水5.37%。截至发稿，该股报133.58美元/股，成交量16.4162万股，换手率0.16%，振幅5.30%。最近的财报数据显示，该股实现营业收入18.87亿美元，净利润2.50亿美元，每股收益2.56美元，毛利18.30亿美元，市盈率54.53倍。神经分泌生物科学股票所在的制药行业中，整体涨幅为0.05%。该公司推动中枢神经系统和内分泌相关类别的候选药物的发展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032722111487e7c4f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032722111487e7c4f5&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421904174","title":"神经分泌生物科学盘中异动 股价大涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421904174","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421904174?lang=zh_cn&edition=full","pubTime":"2024-03-21 21:56","pubTimestamp":1711029363,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日21时56分，神经分泌生物科学股票出现波动，股价急速拉升5.13%。截至发稿，该股报147.86美元/股，成交量46.4254万股，换手率0.47%，振幅5.86%。其相关个股中，大自然药业、神经分泌生物科学、Mira Pharmaceuticals, Inc.涨幅较大，Petros Pharmaceuticals, Inc.、Agile Therapeutics, Inc.、Rockwell Medical, Inc.较为活跃，换手率分别为6.31%、4.31%、3.10%，振幅较大的相关个股有Clever Leaves Holdings Inc C/Wts 18/12/2025、Rockwell Medical, Inc.、Incannex Healthcare Inc.，振幅分别为40.00%、10.30%、10.26%。消息层面，截至21时56分，神经分泌生物科学股票正面舆情新闻比例100%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032121560387e7aba8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032121560387e7aba8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413273894","title":"美国研究综述-Biomarin Pharmaceutical、Intuit、Penumbra","url":"https://stock-news.laohu8.com/highlight/detail?id=2413273894","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2413273894?lang=zh_cn&edition=full","pubTime":"2024-02-23 15:28","pubTimestamp":1708673314,"startTime":"0","endTime":"0","summary":"    路透社2月23日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，其中包括 Biomarin Pharmaceutical、Intuit 和 Penumbra。要闻             * Biomarin Pharmaceutical Inc   ：Piper Sandler将目标价从115美元下调至107美元             * Intuit Inc   ：Susquehanna将目标价从700美元上调至775美元             * Penumbra Inc   ：摩根大通将其评级从 \"增持 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2393460490","title":"神经分泌生物科学盘中异动 早盘股价大涨5.03%报127.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2393460490","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2393460490?lang=zh_cn&edition=full","pubTime":"2023-12-22 22:35","pubTimestamp":1703255710,"startTime":"0","endTime":"0","summary":"北京时间2023年12月22日22时35分，神经分泌生物科学股票出现异动，股价急速上涨5.03%。截至发稿，该股报127.25美元/股，成交量13.0613万股，换手率0.13%，振幅3.40%。神经分泌生物科学股票所在的制药行业中，整体涨幅为0.23%。该公司推动中枢神经系统和内分泌相关类别的候选药物的发展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202312222235107903147b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202312222235107903147b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2391169949","title":"韦德布什：2024年买这些生物科技股吧","url":"https://stock-news.laohu8.com/highlight/detail?id=2391169949","media":"新浪财经","top":-1,"share":"https://www.laohu8.com/m/news/2391169949?lang=zh_cn&edition=full","pubTime":"2023-12-15 22:46","pubTimestamp":1702651602,"startTime":"0","endTime":"0","summary":"进入2024年，韦德布什认为生物技术行业早该恢复正增长了，特别是在中小型股。韦德布什在2024年的热门选择包括Ascendis Pharma、Neurocrine Biosciences和Sarepta Therapeutics。韦德布什认为，生物技术在10月份达到了最低点，随着更多的成功项目，该行业在2024年内可能会走高。韦德布什指出，尽管2023年给生物技术投资者带来了许多挑战，但估值过高并不是其中之一，资本市场仍然对生物技术公司开放。韦德布什继续认为，到2024年，这种情况将继续存在。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023121522491583fc9125&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023121522491583fc9125&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.neurocrine.com","stockEarnings":[{"period":"1week","weight":-0.0552},{"period":"1month","weight":-0.0529},{"period":"3month","weight":-0.0066},{"period":"6month","weight":0.1739},{"period":"1year","weight":0.2818},{"period":"ytd","weight":-0.0002}],"compareEarnings":[{"period":"1week","weight":-0.0275},{"period":"1month","weight":-0.0106},{"period":"3month","weight":0.0622},{"period":"6month","weight":0.1726},{"period":"1year","weight":0.223},{"period":"ytd","weight":0.0613}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Neurocrine Biosciences, Inc.于1992年1月在加利福尼亚州注册成立，并于1996年5月在特拉华州重新注册成立。该公司是一家专注于神经科学的生物制药公司，目的很简单：为有巨大需求的人减轻痛苦，但选择很少。三十年来，该公司运用对神经科学以及大脑和身体系统之间相互联系的独特见解，推进用于治疗未得到充分解决的神经、神经内分泌和神经精神疾病的药物，他们将继续不懈地追求药物，以减轻令人衰弱的疾病和紊乱的负担。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.066296},{"month":2,"riseRate":0.321429,"avgChangeRate":-0.00768},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.006842},{"month":4,"riseRate":0.357143,"avgChangeRate":-0.013566},{"month":5,"riseRate":0.592593,"avgChangeRate":0.047818},{"month":6,"riseRate":0.5,"avgChangeRate":0.019514},{"month":7,"riseRate":0.464286,"avgChangeRate":-0.003857},{"month":8,"riseRate":0.535714,"avgChangeRate":0.024904},{"month":9,"riseRate":0.571429,"avgChangeRate":0.032175},{"month":10,"riseRate":0.535714,"avgChangeRate":0.029555},{"month":11,"riseRate":0.571429,"avgChangeRate":0.038168},{"month":12,"riseRate":0.642857,"avgChangeRate":0.042544}],"exchange":"NASDAQ","name":"神经分泌生物科学","nameEN":"Neurocrine Biosciences"},"APP":{"userAgent":"claudebot","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"神经分泌生物科学(NBIX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供神经分泌生物科学(NBIX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"神经分泌生物科学,NBIX,神经分泌生物科学股票,神经分泌生物科学股票老虎,神经分泌生物科学股票老虎国际,神经分泌生物科学行情,神经分泌生物科学股票行情,神经分泌生物科学股价,神经分泌生物科学股市,神经分泌生物科学股票价格,神经分泌生物科学股票交易,神经分泌生物科学股票购买,神经分泌生物科学股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"神经分泌生物科学(NBIX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供神经分泌生物科学(NBIX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}